ViiV Healthcare UK Ltd

Stockley Park West, Uxbridge, Middlesex,, UB11 1BT, UK
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328

Patient Information Leaflet last updated on the eMC: 09/02/2012
PIL Retrovir 100 mg/10ml, oral solution

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 09/02/2012 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to drug interactions
Updated on 07/12/2011 and displayed until 09/02/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change to manufacturer contact details
Updated on 09/08/2011 and displayed until 07/12/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to Marketing Authorisation Holder
  • Change to Marketing Authorisation Number
Updated on 16/12/2008 and displayed until 09/08/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to dosage and administration
Updated on 02/05/2008 and displayed until 16/12/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 26/03/2008 and displayed until 02/05/2008
Reasons for adding or updating:
  • Change due to user-testing of patient information
  • Change to date of revision
Updated on 25/08/2005 and displayed until 26/03/2008
Reasons for adding or updating:
  • Change to side-effects
Updated on 28/06/2004 and displayed until 25/08/2005
Reasons for adding or updating:
  • Change to information about pregnancy or lactation
Updated on 10/12/2003 and displayed until 28/06/2004
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   zidovudine